Dollar has Stage 4 Cancer – Rob

New Post Public Reply Private Reply Replies (2) Message Board
wowhappens28 100MPH #73829
302
Dollar has Stage 4 Cancer – Rob Kirby

https://usawatchdog.com/dollar-has-stage-4-cancer-rob-kirby/

By Greg Hunter
On December 7, 2021

Macroeconomic analyst Rob Kirby has long predicted Fed money printing would have to go “on a vertical curve where money has to be added to the system . . . to keep the system from crapping out and imploding.” Kirby said this more than a year ago. Massive money printing can no longer be hidden, and it has disastrous and dire implications for the dollar. Kirby explains, “They are not hiding it. It’s too big. If you have an elephant under your carpet in the living room, you can’t say ignore the bump. Elephants are hard to hide. It’s also hard to hide $150 billion in daily turnover in cryptos. That translates into a $54 trillion annual run rate. That means trade settlement. This is admitting there is trade settlement in dollars, and that amount is growing. The dollar is on this exponential growth curve. More dollars are being pushed into the world market every year, and fewer of them are being used in trade settlement. What happens when dollars are not used in trade settlement? They return home. The dollars are returning home, and that’s why the price for everything in America is going up. That’s why the equity markets are higher when fundamentals say the equity markets should be down. We have a huge swath of the economy in America that is still shuttered from this supposed pandemic.”

Kirby contends we are getting closer to a dollar crash. Kirby says, “Until it gets so tall that it looks like the World Trade Center, and you know what happens when things get that tall? They come down in a heap, and that’s what’s going to happen with the dollar. It’s going to come down in a heap just like the World Trade Center. It’s going to be fast, and it’s going to be brutal. That’s where we are headed, and the powers that be know it. That’s what they are keeping from us. That’s why we have the censorship on social media. That’s why people who talk authoritatively about reality are censored and cut off because we are in trouble. They don’t want us to know, and I think they want a lot of us eliminated.”

Does that mean gold and silver have lost their shine to crypto currency? No way, and Kirby predicts, “Metal prices are suppressed. . . . There is going to come a day when metal prices will free itself from the shackles it is currently engaged with. When that occurs, precious metals, in my view, will exceed what we have seen in the crypto universe. What we have seen in crypto currency in the last year or two, I think we could see that in spades in precious metals. . . . The dollar has stage 4 cancer right now. Best you have insurance to cover yourself when the dollar does what it is destined to do.”

Join Greg Hunter as he goes One-on-One on Rumble with analyst Rob Kirby, founder of KirbyAnalytics.com. (There is much more in the 33 min. interview.) 12.07.21

After the Interview:

Kirby recently wrote for friends and subscribers, “There was a time it took Bernie Madoff a couple of decades to bilk $50 billion out of a bunch of chumps. Then we got to the point that it took 17 years for officialdom to squeeze “a missing $21 Trillion” out of a lemon through dubious government accounting gimmickry. Now, we have finally arrived at the point where we can make $400 billion go “poof” in 12 hours. (As happened this past Saturday in the crypto markets.)

A dollar sure doesn’t buy what it used to, eh? Isn’t that progress?”

There is free information on KirbyAnalytics.com. If you want more cutting edge original macro-economic analysis, you can become a subscriber by clicking here.

https://usawatchdog.com/dollar-has-stage-4-cancer-rob-kirby/




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Savvas Launches Miller & Levine Biology Program Revamp

Updated Category News Views 35

Education Meets Innovation: Savvas Takes a Bold Step Who would have thought biology education could get a makeover that might actually stick? Savvas Learning Company thinks it's onto something with the launch of the all-new Miller & Levine Experience Biology Program. The spotlight's on innovation—it's about time someone shook up the way high schoolers learn biology. A...

Continue Reading
Factory-Built Homes Take Center Stage in New Doc Short

Updated Category News Views 88

Housing is one of those things we all think we understand until we start peeling back the layers of its history, especially when factory-built homes are involved. Here's a new angle: Clayton has just released the teaser for their documentary short, "Built: A Story of Factory-Built Housing in America," and it's turning the lights on a sector that's often left in the...

Continue Reading
transcosmos: Not Just Calls—Evolving Business Strategy

Updated Category News Views 110

Turning Talk into Triumphs Award chatter isn't exactly rare in this industry, but the latest accolades rolling in for transcosmos from the Best Contact Center Indonesia 2026 ain't your run-of-the-mill pat on the back. Sure, a trophy's a trophy, but when they snatch Gold in the Business Contribution category and another shiny Silver in People Development, it’s hinting at...

Continue Reading
Unicycive Faces Legal Heat: Shareholder Lawsuit Looms

Updated Category News Views 104

The Unicycive Landslide: What Went Down? Investors, buckle up. Unicycive Therapeutics Inc. (NASDAQ: UNCY) finds itself deep in the muck of a securities class action. Chief honchos, CEO Shalabh Gupta and CFO John Townsend, are taking the heat for allegedly controlling company disclosures that led shareholders to believe in non-existent progress with their third-party...

Continue Reading
SoftwareOne Triumphs in 2026 GitHub Partner Awards

Updated Category News Views 43

SoftwareOne Nabs Prestigious GitHub Honor Outta nowhere, SoftwareOne's been lashed onto the center stage, bagging GitHub's Global Channel Sales Partner of the Year for 2026. This ain't just another shiny trophy on the shelf; it's a solid nod to their grit and strategy. Now, if good old GitHub says you're their top dog, you're obviously doing something right. Not bad for a...

Continue Reading
Data Centers Drive Surge in Power and Cooling Demand

Updated Category News Views 23

Data Centers: The Unseen Powerhouses Don't let the tech jargon fool you—data centers are more than just server rooms. They're beastly energy guzzlers, and their demand is rippling through the supply chain in a big way. You've got companies like Vertiv, American Tower, Johnson Controls, and Generac riding high on this trend, making some serious waves in their quarterly...

Continue Reading
Data Breach at Lumara Bio: Privacy Lawsuits Loom

Updated Category News Views 28

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Continue Reading
Jacobi's Harness Brings AI from Concept to Reality

Updated Category News Views 160

The Challenge of Moving AI to Production Diving headfirst into AI in finance? Well, Jacobi's bold move with their new toy, the Investment Management Harness, spotlights a filthy secret: the hurdles between a big idea and execution are seldom technological. We got AI shaving prototyping time down to just days, yet pushing to production? That's a marathon in itself. Boards...

Continue Reading
Air Canada-CAE Scholarship Drives Women in Aviation

Updated Category News Views 88

A New Chapter for Women in Aviation Call it paving the skies or busting the glass cockpit ceiling, but Air Canada and CAE are really doubling down on getting more women into aviation. They're rolling out the eighth annual Captain Judy Cameron Scholarship, set to open applications on November 1, 2026. With up to eight scholarships on the table for Canadian women eyeing...

Continue Reading
H.R. 10549: Hope Charities Pushes for Pharmacy Freedom

Updated Category News Views 63

Hope Charities Takes a Stand for Patients In Prairieville, Hope Charities is throwing its weight behind a bill they believe is brewing up a patient revolution. The Patients Choice in Specialty Pharmacy Act, otherwise known as H.R. 10549, sparked by Representatives Neal Dunn and Joe Wilson, tackles the comfortable partnerships some insurers have been enjoying with their...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative AI Assistant by ClickBid Revolutionizes Fundraising

Updated Category News Views 155

ClickBid Introduces Groundbreaking AI Assistant ClickBid, recognized as a pioneer in event fundraising technology, proudly presents ClickBid Search. This is the first custom GPT-powered AI assistant tailored specifically for nonprofits, designed to offer immediate and relevant answers to help organizations optimize their event strategies. Available at no cost to all...

Continue Reading
TIER IV and TUM Drive Level 4 Autonomous Cars

Updated Category News Views 25

Autonomous Driving Gets a German Boost Well folks, looks like the autonomous vehicle scene is hitting the autobahns with more horsepower than ever before. Today’s chatter is all about how TIER IV and the Technical University of Munich (TUM) have teamed up, tapping into the grid as they ride the waves of cutting-edge NVIDIA tech. The Sparks Under the Hood: NVIDIA...

Continue Reading
Vericel Corporation's Upcoming Presentation at MedTech Conference

Updated Category News Views 147

Vericel Corporation's Engagement at the MedTech Conference CAMBRIDGE, Mass. — Vericel Corporation (NASDAQ:VCEL), a recognized leader in advanced therapies for sports medicine and severe burn care, has exciting news regarding its participation at the upcoming Truist Securities MedTech Conference. The company will be featured in a fireside chat, slated to take place at...

Continue Reading
Gildan Achieves Strong Q2 Results: Revenue and Finances Surge

Updated Category News Views 128

Gildan Reports Remarkable Growth in Second Quarter Earnings Gildan Activewear Inc. (NYSE: GIL, TSX: GIL) has achieved record net sales of $919 million during the second quarter, reflecting a strong 6.5% increase compared to the previous year. Strong Operational Performance and Profitability This quarter's operating margin stood at an impressive 21.7%, with an adjusted...

Continue Reading
MimiVax and UI Pharmaceuticals Mark Key Production Milestone

Updated Category News Views 260

MimiVax and UI Pharmaceuticals Mark Key Production Milestone MimiVax and UI Pharmaceuticals have achieved an exciting development in the field of cancer treatment with the clinical manufacture of SurVaxM, an innovative immunotherapeutic vaccine aimed at targeting glioblastoma. SurVaxM proudly stands out as the first product to be manufactured at UI Pharmaceuticals' newly...

Continue Reading